Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular

Effects of panitumumab against oesophageal-gastro cancer and carcinomas

Dr Tom Waddell – Royal Marsden Hospital, Sutton, UK
Effects of panitumumab against oesophageal-gastro cancer and carcinomas ( Dr Tom Waddell – Royal Marsden Hospital, Sutton, UK )
15 Jun 2012

Effects of lapatinib and trastuzumab on progression free survival

Dr Nancy Lin – Dana Farber Cancer Institute, Boston, MA, USA
Effects of lapatinib and trastuzumab on progression free survival ( Dr Nancy Lin – Dana Farber Cancer Institute, Boston, MA, USA )
15 Jun 2012

Decision making in surgical breast cancer treatment

Dr Monica Morrow – Memorial Sloan-Kettering Cancer Center, New York, NY, USA
Decision making in surgical breast cancer treatment ( Dr Monica Morrow – Memorial Sloan-Kettering Cancer Center, New York, NY, USA )
15 Jun 2012

President's overview of ASCO 2012

Dr Michael Link - Stanford School of Medicine, California, USA
President's overview of ASCO 2012 ( Dr Michael Link - Stanford School of Medicine, California, USA )
4 Jun 2012

New BRAF inhibitor dabrafenib delays disease progression in advanced melanoma

Dr Axel Hauschild - Universitaetsklinikum Schleswig-Holstein, Germany
New BRAF inhibitor dabrafenib delays disease progression in advanced melanoma ( Dr Axel Hauschild - Universitaetsklinikum Schleswig-Holstein, Germany )
4 Jun 2012

Increased risk of breast cancer among young women treated with radiation as a child

Dr Chaya Moskowitz - Memorial Sloan-Kettering Cancer Center, New York, USA
Increased risk of breast cancer among young women treated with radiation as a child ( Dr Chaya Moskowitz - Memorial Sloan-Kettering Cancer Center, New York, USA )
4 Jun 2012

New MEK inhibitor, trametinib, improves survival in advanced melanoma

Dr Caroline Robert - Institut Gustave Roussy, Villejuif, France
New MEK inhibitor, trametinib, improves survival in advanced melanoma ( Dr Caroline Robert - Institut Gustave Roussy, Villejuif, France )
4 Jun 2012

Afatinib delays progression of advanced lung adenocarcinomas

Dr James Yang - National Taiwan University Hospital, Taipei
Afatinib delays progression of advanced lung adenocarcinomas ( Dr James Yang - National Taiwan University Hospital, Taipei )
4 Jun 2012

Costly drugs versus paclitaxel as first line therapy for locally advanced or metastatic breast cancer

Dr Hope Rugo - University of California San Francisco, USA
Costly drugs versus paclitaxel as first line therapy for locally advanced or metastatic breast cancer ( Dr Hope Rugo - University of California San Francisco, USA )
4 Jun 2012

Regorafenib effective for GISTs that progress due to resistance to approved targeted therapies

Dr George Demetri - Dana Farber Cancer Institute, Boston, USA
Regorafenib effective for GISTs that progress due to resistance to approved targeted therapies ( Dr George Demetri - Dana Farber Cancer Institute, Boston, USA )
4 Jun 2012

EMILIA trial: Trastuzumab emtansine improves progression-free survival in HER2-positive breast cancer

Dr Kimberly Blackwell - Duke University Medical Center, Durham, USA
EMILIA trial: Trastuzumab emtansine improves progression-free survival in HER2-positive breast cancer ( Dr Kimberly Blackwell - Duke University Medical Center, Durham, USA )
3 Jun 2012

Increased progression-free survival in advanced lung cancer with afatinib

Dr James Yang - National Taiwan University Hospital Taipei, Taiwan
Increased progression-free survival in advanced lung cancer with afatinib ( Dr James Yang - National Taiwan University Hospital Taipei, Taiwan )
3 Jun 2012

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation